Downgrade Alert for OraSure Technologies (OSUR)
OraSure Technologies (NASDAQ:OSUR) was downgraded from Outperform to Market Perform at Raymond James today. The stock closed yesterday at $6.83 on volume of 1.7 million shares, above average daily volume of 465,000.
OraSure Technologies, Inc. develops, manufactures, and markets medical devices and diagnostic products. The Company supplies oral fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV. OraSure also supplies oral fluid testing solutions for drugs-of-abuse testing.
OraSure Technologies share prices have moved between a 52-week high of $14.01 and a 52-week low of $3.75 and closed yesterday at 82% above that low price at $6.83 per share. The 200-day and 50-day moving averages have moved 0.53% higher and 0.58% higher over the past week, respectively.
There is potential upside of 8.3% for shares of OraSure Technologies based on a current price of $6.83 and an average consensus analyst price target of $7.40. The stock should find resistance at its 50-day moving average (MA) of $7.04, as well as support at its 200-day MA of $5.97.
SmarTrend recommended that subscribers consider buying shares of OraSure Technologies on February 10th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $6.52. Since that recommendation, shares of OraSure Technologies have risen 19.4%. We continue to monitor OSUR for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: analyst upgrades/downgrades orasure technologies